"Mind blown. The responses it gave were pulled from sources we trust, but also based on what it was hearing in the visit in real time. The updated Abridge clinical decision support just blew me away." —Hematology/Oncology & Palliative Care Clinician at a large, urban health system Abridge Clinical Decision Support surfaces relevant, evidence-based information at the point of care. When clinicians ask questions, CDS insights are grounded in the clinical conversation, EHR context, and informed by a growing list of trusted sources: - UpToDate (owned by Wolters Kluwer) - The New England Journal of Medicine - JAMA (published by AMA) - American Heart Association - American Diabetes Association - American Family Physician (published by AAFP) - Journal of Clinical Oncology (published by ASCO) - Neurology (published by AAN) - EBMCalc No more surfing tabs. No more switching context. No more turning away from the patient. Just the information you need, exactly when you need it, grounded in clinical context. Learn more at

Earlier today, Moderna and Merck presented 5-year follow-up data for intismeran autogene in combination with KEYTRUDA® (pembrolizumab) in patients with high-risk melanoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Watch our latest IR Insights video below to hear more from our CEO Stéphane Bancel and Chief Development Officer David Berman about these results. #ASCO2026# #ASCO26#